查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1819918

2025-2033 年血液製剂市场报告（按产品、抗血栓和抗凝血剂类型、抗血栓和抗凝血剂应用和地区划分）

Blood Preparation Market Report by Product, Antithrombotic and Anticoagulants Type, Antithrombotic and Anticoagulants Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球血液製剂市场规模达462亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到669亿美元，2025-2033年期间的复合年增长率（CAGR）为3.98%。由于慢性病患病率上升、政府出台改善医疗基础设施的倡议、公众意识增强导致捐血量增加、血液处理技术的快速进步以及个性化医疗的日益普及，市场规模正在不断扩大。

血液製剂市场趋势：

慢性病盛行率不断上升

心血管疾病、癌症和糖尿病等慢性病的增多是积极影响血液製剂市场动态的主要因素之一。根据产业研究，美国约有 1.29 亿人患有至少一种主要慢性病。这些疾病会导致贫血、凝血障碍和免疫系统缺陷等併发症，需要频繁输血、血小板替代疗法和血浆治疗。例如，根据美国国家血液采集和使用调查 (NBCUS) 报告，2021 年美国输血量为 10,764,000 单位全血提取和单采红血球 (RBC)。此外，全球老年人口不断增长，加剧了输血需求，因为这些人更容易患慢性疾病和相关併发症，这也促进了该行业的扩张。

政府措施及医疗基础建设发展介绍

政府推出各种措施来改善医疗基础设施和确保稳定的血液供应，这扩大了血液製剂市场的规模。政府越来越重视投资于促进捐血、改善血库设施和提高血液製品整体安全性和可用性的倡议，这推动了市场的成长。例如，印度政府 (GOI) 透过输血服务，一直支持公共和慈善部门的 1131 个血库，包括人力、血袋和检测试剂盒的采购、自愿捐血 (VBD) 营的开展以及资讯教育交流 (IEC) 活动。此外，各国政府正在实施严格的措施来确保血液製品的品质和安全，这有助于在医疗服务提供者和患者之间建立信任。例如，印度政府为监控血库而采取的一项措施 e-RaktKosh，是一个整合的血库管理资讯系统，将所有血库互连成一个网路。

提高认识，增加捐血量

在全球范围内，人们对捐血重要性的认识日益加深，捐血人数不断增加，这推动了血液製剂市场的份额成长。据估计，美国每年约有680万人捐血，采集的全血和红血球数量达1,360万单位。此外，政府、非政府组织（NGO）和医疗机构主导公共卫生运动和倡议，向公众宣传捐血在拯救生命方面的重要性，也促进了市场的成长。同时，已开发国家和发展中国家对血液製品的需求不断增长，促使捐血系统更加结构化、组织化，从而确保了血液供应的稳定可靠，这也推动了市场的成长。

血液製剂市场细分：

按产品分类：

  • 全血
    • 红血球
    • 粒细胞
    • 电浆
    • 血小板
  • 血液成分
    • 全血成分
    • 红血球压积
    • 白血球减少的红血球
    • 冷冻血浆
    • 浓缩血小板
    • 冷沉淀物
  • 血液衍生物

全血占据大部分市场份额

根据血液製剂市场分析，全血因其在各种医疗治疗中的广泛应用而占据市场主导地位，包括外科手术、创伤护理以及为严重贫血或失血患者输血。此外，全血含有所有必需成分，例如红血球、白血球、血小板和血浆，使其适用于多种临床应用。此外，在急诊和重症监护环境中对全血的需求不断增长，加上其在救命手术中的关键作用，也推动了市场的成长。

依抗血栓和抗凝血剂类型分解：

  • 血小板聚集抑制剂
    • 糖蛋白抑制剂
    • COX抑制剂
    • ADP拮抗剂
    • 其他的
  • 纤溶药物
    • 组织型纤溶酶原激活剂（TPA）
    • 链激酶
    • 尿激酶
  • 抗凝血剂
    • 肝素
    • 维生素K拮抗剂
    • 直接凝血酶抑制剂
    • 直接Xa因子抑制剂

抗凝血剂占产业最大份额

根据血液製剂市场概况，抗凝血剂占据了最大的市场份额，这得益于其在预防和治疗血栓方面的关键作用，而血栓在深部静脉栓塞、肺栓塞和心房颤动等疾病中很常见。此外，抗凝血剂对于治疗血栓相关疾病以及降低中风和心臟病发作的风险至关重要。此外，抗凝血剂在外科手术和心血管疾病患者的长期治疗中的频繁使用也促进了市场的成长。此外，老年人口的不断增长（老年人更容易患上凝血障碍）以及安全性和有效性更高的新型抗凝血剂疗法的开发，正在推动血液製剂市场的成长率。

抗血栓和抗凝血剂的分解应用：

  • 血小板增多症
  • 肺栓塞
  • 肾功能不全
  • 心绞痛血管併发症
  • 其他的

血小板增多症是领先的细分市场

根据血液製剂市场预测，血小板增多症占据了最大的市场份额，这是由于导致血小板计数升高的疾病（例如骨髓增生性疾病）的盛行率不断上升。此外，血小板增多症常导致过多的血栓形成，进而引发中风或心臟病等严重併发症。抗凝血剂和抗血栓治疗对于预防异常凝血至关重要。此外，人们对血小板增多症认识的不断提高、诊断工具的快速进步以及标靶抗凝血治疗的普及，正在推动市场的成长。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美领先市场，占据最大血液製剂市场份额

该报告还对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告指出，北美是血液製剂最大的区域市场。

根据血液製剂市场报告，北美地区凭藉其完善的医疗基础设施、高发生率的慢性病和庞大的医疗支出，占据了市场领先地位。此外，癌症、心血管疾病和贫血等需要定期输血和血小板治疗的疾病发生率不断上升，导致血液製品需求不断增长，这也推动了市场的成长。此外，先进医疗技术的引入、对血液安全的高度重视以及该地区庞大的捐血中心网络，也是血液製剂市场的主要驱动力。

（请注意，这只是关键参与者的部分名单，完整名单将在报告中提供。）

  • 市场领导者正专注于策略合作、产品创新和地理扩张，以巩固其市场地位。他们正在投资研发，引进先进的血液製品和技术，以提高安全性和有效性。此外，一些公司正在提升生产能力，以满足日益增长的血浆衍生疗法和其他血液成分的需求。此外，他们还与医院、血库和医疗机构建立合作伙伴关係，以确保稳定的供应链并提高可及性。

本报告回答的关键问题

  • 2024年全球血液製剂市场规模为多少
  • 2025-2033年全球血液製剂市场的预期成长率是多少
  • 推动全球血液製剂市场的关键因素有哪些
  • COVID-19 对全球血液製剂市场有何影响
  • 根据产品类型，全球血液製剂市场如何划分？
  • 根据抗血栓和抗凝血剂类型，全球血液製剂市场如何划分
  • 根据抗血栓和抗凝血剂的应用，全球血液製剂市场如何分布
  • 全球血液製剂市场重点区域有哪些
  • 全球血液製剂市场的主要参与者/公司有哪些

本报告回答的关键问题

  • 2024年全球血液製剂市场规模？ 2025-2033年全球血液製剂市场的预期成长率是多少？
  • 推动全球血液製剂市场发展的关键因素有哪些？
  • COVID-19 对全球血液製剂市场有何影响？
  • 根据产品，全球血液製剂市场是如何分布的？
  • 根据抗血栓和抗凝血剂类型，全球血液製剂市场是如何分布的？
  • 根据抗血栓和抗凝血剂的应用，全球血液製剂市场是如何分布的？
  • 全球血液製剂市场的主要区域有哪些？
  • 全球血液製剂市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球血液製剂市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 全血
    • 关键部分
      • 红血球
      • 粒细胞
      • 电浆
      • 血小板
  • 血液成分
    • 关键部分
      • 全血成分
      • 红血球压积
      • 白血球减少的红血球
      • 冷冻血浆
      • 浓缩血小板
      • 冷沉淀物
  • 血液衍生物

第七章：市场区隔：按抗血栓和抗凝血剂类型

  • 血小板聚集抑制剂
    • 关键部分
      • 糖蛋白抑制剂
      • COX抑制剂
      • ADP拮抗剂
      • 其他的
  • 纤溶药物
    • 关键部分
      • 组织型纤溶酶原激活剂（TPA）
      • 链激酶
      • 尿激酶
  • 抗凝血剂
    • 关键部分
      • 肝素
      • 维生素K拮抗剂
      • 直接凝血酶抑制剂
      • 直接Xa因子抑制剂

第 8 章：市场区隔：按抗血栓和抗凝血剂的应用

  • 血小板增多症
  • 肺栓塞
  • 肾功能不全
  • 心绞痛血管併发症
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Baxter International Inc.
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • Daiichi Sankyo Company Limited
    • GlaxoSmithKline PLC
    • Johnson & Johnson Services Inc.
    • LEO Pharma A/S
    • Pfizer Inc.
    • Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.)
    • Sanofi SA
Product Code: SR112025A4552

The global blood preparation market size reached USD 46.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 66.9 Billion by 2033, exhibiting a growth rate (CAGR) of 3.98% during 2025-2033. The market is expanding due to the rising prevalence of chronic diseases, imposition of government initiatives that improve healthcare infrastructure, growing public awareness leading to increased blood donations, rapid advancements in blood processing technology, and the increasing adoption of personalized medicine.

Blood Preparation Market Trends:

Increasing Prevalence of Chronic Diseases

The rise in chronic diseases, including cardiovascular conditions, cancer, and diabetes, is one of the major factors positively impacting the blood preparation market dynamics. As per industry research, an estimated 129 million people in the U.S. have at least one major chronic disease. These diseases are known to result in complications such as anemia, clotting disorders, and immune system deficiencies, which require frequent blood transfusions, platelet replacement therapy, and plasma treatments. For instance, according to the National Blood Collection and Utilization Survey (NBCUS) report, in 2021, 10,764,000 units of whole blood-derived and apheresis red blood cells (RBCs) were transfused in the United States. Moreover, the growing geriatric population across the globe, exacerbating the need for blood transfusion as these individuals are more prone to chronic illnesses and associated complications, is bolstering the expansion of this industry.

Introduction of Government Initiatives and Healthcare Infrastructure Development

The introduction of various government initiatives to improve healthcare infrastructure and ensure a stable blood supply is enhancing the blood preparation market size. The increasing government focus on investing in initiatives that promote blood donation, improve blood bank facilities, and enhance the overall safety and availability of blood products is boosting the market growth. For instance, the Government of India (GOI), through blood transfusion services, has been supporting 1131 blood banks in the public and charitable sector with respect to manpower, procurement of blood bags and testing kits, conduction of voluntary blood donation (VBD) camps, and information education communication (IEC) activities. In addition, governments are implementing stringent measures to ensure the quality and safety of blood products, which helps build trust among healthcare providers and patients. For example, e-RaktKosh, an initiative of the Government of India to monitor the blood banks, is an integrated blood bank management information system that interconnects all the blood banks into a single network.

Growing Awareness and Increasing Blood Donations

The growing awareness about the importance of blood donation and the increasing number of blood donors across the globe are boosting the blood preparation market share. Each year, an estimated 6.8 million people in the U.S. donate blood, and 13.6 million units of whole blood and red blood cells are collected. Moreover, the introduction of public health campaigns and initiatives led by governments, non-governmental organizations (NGOs), and healthcare providers to educate the public about the life-saving importance of donating blood is bolstering the market growth. Along with this, the growing demand for blood products in developed and developing countries that is leading to more structured and organized blood donation systems, which ensure a steady and reliable supply of blood, is fueling the market growth.

Blood Preparation Market Segmentation:

Breakup by Product:

  • Whole Blood
    • Red Cells
    • Granulocytes
    • Plasma
    • Platelets
  • Blood Components
    • Whole Blood Components
    • Packed Red Cells
    • Leukocyte Reduced Red Blood Cells
    • Frozen Plasma
    • Platelet Concentrate
    • Cryoprecipitate
  • Blood Derivatives

Whole blood accounts for the majority of the market share

As per the blood preparation market analysis, whole blood dominated the market due to its widespread use in various medical treatments, including surgeries, trauma care, and transfusions for patients with severe anemia or blood loss. Moreover, it contains all essential components, such as red cells, white cells, platelets, and plasma, making it versatile for multiple clinical applications. Besides this, the growing demand for whole blood in emergency and critical care settings, coupled with its crucial role in life-saving procedures, is contributing to the market growth.

Breakup by Antithrombotic and Anticoagulants Type:

  • Platelet Aggregation Inhibitors
    • Glycoprotein Inhibitors
    • COX Inhibitors
    • ADP Antagonists
    • Others
  • Fibrinolytics
    • Tissue Plasminogen Activator (TPA)
    • Streptokinase
    • Urokinase
  • Anticoagulants
    • Heparins
    • Vitamin K Antagonists
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors

Anticoagulants holds the largest share of the industry

Based on the blood preparation market overview, anticoagulants accounted for the largest market, driven by their critical role in preventing and treating blood clots, which are common in conditions such as deep vein thrombosis, pulmonary embolism, and atrial fibrillation. Moreover, anticoagulants are essential for managing clot-related disorders and reducing the risk of strokes and heart attacks. Besides this, their frequent use in surgical procedures and long-term treatments for patients with cardiovascular conditions is enhancing the market growth. Along with this, the increasing geriatric population, which is more prone to clotting disorders, and the development of newer anticoagulant therapies that offer improved safety and efficacy profiles are boosting the blood preparation market growth rate.

Breakup by Antithrombotic and Anticoagulants Application:

  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others

Thrombocytosis represents the leading market segment

According to the blood preparation market forecast, thrombocytosis represented the largest share in the market, due to the increasing prevalence of conditions that cause elevated platelet counts, such as myeloproliferative disorders. Moreover, thrombocytosis often leads to excessive blood clot formation, which can result in severe complications like strokes or heart attacks. Anticoagulants and antithrombotic therapies are critical for managing this condition by preventing abnormal clotting. Along with this, the growing awareness of thrombocytosis, rapid advancements in diagnostic tools, and the availability of targeted anticoagulant treatments are driving the market growth.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest blood preparation market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for blood preparation.

As per the blood preparation market report, North America is leading the market, driven by its well-established healthcare infrastructure, high prevalence of chronic diseases, and significant healthcare spending. Moreover, the growing demand for blood products, fueled by the growing incidence of conditions such as cancer, cardiovascular diseases, and anemia, which require regular blood transfusions and platelet therapies, is bolstering the market growth. Besides this, the introduction of advanced medical technologies, a strong emphasis on blood safety, and a large network of blood donation centers in the region are acting as major blood preparation market drivers.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the blood preparation industry include Baxter International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., LEO Pharma A/S, Pfizer Inc., Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.), Sanofi S.A., etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • The leading players in the market are focusing on strategic collaborations, product innovations, and expanding their geographical presence to strengthen their market positions. They are investing in research and development (R&D) to introduce advanced blood products and technologies aimed at improving safety and efficacy. Moreover, several firms are enhancing their production capabilities to meet the rising demand for plasma-derived therapies and other blood components. Besides this, they are forming partnerships with hospitals, blood banks, and healthcare institutions to secure stable supply chains and improve accessibility.

Key Questions Answered in This Report

  • 1.What was the size of the global blood preparation market in 2024?
  • 2.What is the expected growth rate of the global blood preparation market during 2025-2033?
  • 3.What are the key factors driving the global blood preparation market?
  • 4.What has been the impact of COVID-19 on the global blood preparation market?
  • 5.What is the breakup of the global blood preparation market based on the product?
  • 6.What is the breakup of the global blood preparation market based on the antithrombotic and anticoagulants type?
  • 7.What is the breakup of the global blood preparation market based on the antithrombotic and anticoagulants application?
  • 8.What are the key regions in the global blood preparation market?
  • 9.Who are the key players/companies in the global blood preparation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Blood Preparation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Whole Blood
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Red Cells
      • 6.1.2.2 Granulocytes
      • 6.1.2.3 Plasma
      • 6.1.2.4 Platelets
    • 6.1.3 Market Forecast
  • 6.2 Blood Components
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Whole Blood Components
      • 6.2.2.2 Packed Red Cells
      • 6.2.2.3 Leukocyte Reduced Red Blood Cells
      • 6.2.2.4 Frozen Plasma
      • 6.2.2.5 Platelet Concentrate
      • 6.2.2.6 Cryoprecipitate
    • 6.2.3 Market Forecast
  • 6.3 Blood Derivatives
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Antithrombotic and Anticoagulants Type

  • 7.1 Platelet Aggregation Inhibitors
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Glycoprotein Inhibitors
      • 7.1.2.2 COX Inhibitors
      • 7.1.2.3 ADP Antagonists
      • 7.1.2.4 Others
    • 7.1.3 Market Forecast
  • 7.2 Fibrinolytics
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Tissue Plasminogen Activator (TPA)
      • 7.2.2.2 Streptokinase
      • 7.2.2.3 Urokinase
    • 7.2.3 Market Forecast
  • 7.3 Anticoagulants
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Heparins
      • 7.3.2.2 Vitamin K Antagonists
      • 7.3.2.3 Direct Thrombin Inhibitors
      • 7.3.2.4 Direct Factor Xa Inhibitors
    • 7.3.3 Market Forecast

8 Market Breakup by Antithrombotic and Anticoagulants Application

  • 8.1 Thrombocytosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pulmonary Embolism
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Renal Impairment
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Angina Blood Vessel Complications
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Boehringer Ingelheim International GmbH
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bristol-Myers Squibb Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Daiichi Sankyo Company Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 GlaxoSmithKline PLC
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson Services Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 LEO Pharma A/S
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Sanofi S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Blood Preparation Market: Major Drivers and Challenges
  • Figure 2: Global: Blood Preparation Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Blood Preparation Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Blood Preparation Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Type (in %), 2024
  • Figure 6: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Application (in %), 2024
  • Figure 7: Global: Blood Preparation Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Blood Preparation (Whole Blood) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Blood Preparation (Whole Blood) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Blood Preparation (Blood Components) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Blood Preparation (Blood Components) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Blood Preparation (Blood Derivatives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Blood Preparation (Blood Derivatives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Blood Preparation (Fibrinolytics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Blood Preparation (Fibrinolytics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Blood Preparation (Anticoagulants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Blood Preparation (Anticoagulants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Blood Preparation (Thrombocytosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Blood Preparation (Thrombocytosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Blood Preparation (Pulmonary Embolism) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Blood Preparation (Pulmonary Embolism) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Blood Preparation (Renal Impairment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Blood Preparation (Renal Impairment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Blood Preparation (Angina Blood Vessel Complications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Blood Preparation (Angina Blood Vessel Complications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Blood Preparation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Blood Preparation Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Blood Preparation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Blood Preparation Industry: SWOT Analysis
  • Figure 80: Global: Blood Preparation Industry: Value Chain Analysis
  • Figure 81: Global: Blood Preparation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Blood Preparation Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Blood Preparation Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Type (in Million USD), 2025-2033
  • Table 4: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Application (in Million USD), 2025-2033
  • Table 5: Global: Blood Preparation Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Blood Preparation Market: Competitive Structure
  • Table 7: Global: Blood Preparation Market: Key Players